National Health Investors, Inc.
NYSE:NHIREIT - Healthcare Facilities
-$0.30 today
- Market cap
- $3.07B
- Beta
- 0.55
- P/E (TTM)
- 22.9
- EPS (TTM)
- $3.07
- Dividend yield
- 5.21%
Volume 0.74M
Average 0.40M
Returns on capital
National Health Investors, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
9.3%
avg 10.4%
ROIC
7.0%
avg 7.2%
ROA
5.1%
avg 5.3%
Analysis
ROE is currently the strongest return metric at 9.3% versus its period average of 10.4%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
D. Eric Mendelsohn | President, Chief Executive Officer & Director | USD 2.36M | 64 | 133.32K | 0.28% |
Kevin Carlton Pascoe | Executive Vice President of Investments & Chief Investment Officer | USD 1.16M | 45 | 73.08K | 0.15% |
Kristin Sallee Gaines | Senior Vice President & Chief Transaction Officer | USD 798K | 54 | 0 | <0.01% |
David Louis Travis | Senior Vice President & Chief Accounting Officer | USD 753K | 51 | — | — |
Christian Maingot | EVP & Chief Operating Officer | — | — | — | — |
Dana Rolfson Hambly | Senior Vice President of Finance & Investor Relations | — | — | — | — |
Grant Johnston | Senior Vice President Asset Management | — | — | — | — |
Kimberly Ouimet | Director of Corporate Compliance & Human Resources | — | — | — | — |
Todd Siefert | Chief Financial Officer | — | — | — | — |
Beth J. Blankenship | Senior Vice President of Legal Affairs & Corporate Secretary | — | 56 | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jun 5, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$167,027.17
Sells
0
$0.00
Net Transaction Value
+$167,027.17
Net buying
Most Active
MCCABE ROBERT A JR
1 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Jun 15, 26Jun 15, 2026 | MCCABE ROBERT A JR Direct | Buy | $63.8K$63,767.17 |
| Jun 5, 26Jun 5, 2026 | Mendelsohn D. Eric Direct | Buy | $103.3K$103,260.00 |
Summary
Insiders reported 2 buys worth $167,027.17 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $167,027.17. MCCABE ROBERT A JR was the most active insider with 1 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +80.9% | N/A1 analysts |
| Revenue | N/A | N/A | +10.8% | -4.1% (5yr)2 analysts |
| Net Income | N/A | N/A | +28.9% | N/A2 analysts |
| EBIT | N/A | N/A | +13.6% | N/A — |
Analysis
Recent growth has been strongest in EPS at +80.9% over three years. Forward estimates point to Revenue at -4.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does National Health Investors, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about NHI's management, answered from reported figures.
Who manages NHI?
National Health Investors, Inc. (NHI) lists 10 active executives. The top listed executive is Christian Maingot, EVP & Chief Operating Officer.
Are NHI insiders buying or selling?
Recent insider activity shows net selling of $37.46M.
Continue the stock analysis
Jump to another research area for this company.